Impact Biomedical Aktie - IBO

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,56

Gebot

Fragen

Volumen

7.004.295

3,07 Tagesbereich 4,50

0,508 52-Wochen-Bereich 6,17

Handelsende

4,96

Handelsbeginn

3,8312

Letzte Trade

3.56

Letzter Handelszeitpunkt

23:47:22

Durchschnittliches Volumen (3 Mio.)

3.136.708

Finanzvolumen

US$ 25.542.062

VWAP

3,6466

Impact Biomedical Inc. Announcement Stock Activity/Pricing

HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Form 8-K - Current report

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company...

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	2.85	401.408450704	0.71	6.17	0.508	34251474	4.46594148	CS
4	1.43	67.1361502347	2.13	6.17	0.508	8589150	4.45537362	CS
12	1.9	114.457831325	1.66	6.17	0.508	3136708	4.44430422	CS
26	1.13	46.5020576132	2.43	6.17	0.508	1450390	4.38730303	CS
52	0.56	18.6666666667	3	6.17	0.508	1391323	4.37528228	CS
156	0.56	18.6666666667	3	6.17	0.508	1391323	4.37528228	CS
260	0.56	18.6666666667	3	6.17	0.508	1391323	4.37528228	CS

IBO - Frequently Asked Questions (FAQ)

What is the current Impact Biomedical share price?

The current share price of Impact Biomedical is US$ 3,56

What is the 1 year trading range for Impact Biomedical share price?

Impact Biomedical has traded in the range of US$ 0,508 to US$ 6,17 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
DJTUT REX 2X Long DJT Daily Target ETF	US$ 22,40 (15,52%)	574
KNWKnow Labs Inc	US$ 1,20 (14,29%)	23,28k
MSNEmerson Radio Corp	US$ 0,4937 (9,69%)	802
PTNPalatin Technologies Inc New	US$ 0,80 (6,26%)	20,87k
KAPAKairos Pharma Ltd	US$ 1,01 (6,09%)	369
MWGMulti Ways Holdings Limited	US$ 0,281 (-14,75%)	9,57k
ITPIT Tech Packaging Inc	US$ 0,27 (-5,66%)	5,25k
MINFT Limited	US$ 2,11 (-5,59%)	299
YCBDcbdMD Inc	US$ 0,26 (-5,21%)	17,61k
CPHIChina Pharma Holdings Inc	US$ 0,2304 (-5,03%)	500
VOOVanguard S&P 500	US$ 529,00 (-0,07%)	17,41M
IVViShares Core S&P 500	US$ 576,27 (-0,08%)	15,91M
SPYSPDR S&P 500	US$ 573,812 (-0,05%)	14,54M
XLFFinancial Select Sector	US$ 50,0922 (-0,10%)	5,7M
HYGiShares iBoxx Dollar High Yield Corporate Bond	US$ 79,45 (0,00%)	4,96M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Impact Biomedical Inc (IBO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

IBO Neueste Nachrichten

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Form 8-K - Current report

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Form 8-K - Current report

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

IBO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Impact Biomedical Inc (IBO) Börsenkurse

Impact Biomedical Inc (IBO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

IBO Neueste Nachrichten

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Form 8-K - Current report

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Form 8-K - Current report

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

IBO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen